Deal to expand rare disease treatments Avidity to separate early-stage cardiology programs into new company Acquisition to help Novartis gain stronger foothold in US Oct 26 (Reuters) - Swiss drugmaker ...

INDIANAPOLIS (WISH) — Indiana University on Tuesday commenced construction on the IU Launch Accelerator for Biosciences, which is being called IU LAB, in the 16 Tech Innovation District. The goal of ...

Novartis NOVN0.06%increase; green up pointing triangle is acquiring Avidity Biosciences RNA 0.09%increase; green up pointing triangle in a $12 billion deal that the Swiss drugmaker said would further ...

A quiet revolution is reshaping enterprise data engineering. Python developers are building production data pipelines in minutes using tools that would have required entire specia ...

Swiss pharmaceutical giant Novartis announced Sunday it had agreed to buy Avidity Biosciences, valuing the US biopharmaceutical company at $12 billion. "The proposed acquisition is expected to create ...

The Florida government is ridding the Everglades of invasive pythons by allowing fashion brans to turn them into luxury accessories. Inverse Leathers Shopping will now save the planet. Florida ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. TuHURA Biosciences ( (HURA)) has shared ...

The market expects Castle Biosciences, Inc. (CSTL) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known ...

A Seattle biotech startup born from a Nobel laureate's lab has landed $12.7 million and partnerships with pharmaceutical ...

Fashion trend forecasters should flag snake skin as the next big thing in the Sunshine State. The invasive Burmese python, which has been terrorizing the natural wildlife of the Florida Everglades for ...

Fintel reports that on October 27, 2025, Bernstein downgraded their outlook for Avidity Biosciences (NasdaqGM:RNA) from Outperform to Market Perform. Analyst Price Forecast Suggests 41.35% Upside As ...

Inhibrx Biosciences Inc. (NASDAQ:INBX) shares rose 75.95% in after-hours trading on Thursday, closing at $49.90. Check out the current price of INBX stock here. According to Benzinga Pro data, the ...